Abstract
Nanotechnology offers exciting prospects for wide-ranging advances in nearly all aspects of clinical oncology. A rapidly growing armamentarium of nanomaterials and devices such as quantum dots, nanoshells, liposomes, nanocantilever, and nanowires show promise to expand our capabilities for early detection and accurate staging of malignancies, effective targeting of diverse treatment modalities, and monitoring for treatment response. Areas of particular interest to the practice of oncology include improvements in tumor imaging, increased specificity in therapy delivery systems, and the ability to assess cancer biomarkers at low concentrations. Nanoscale devices with multifunctional capabilities are also of value, which would provide options for combining diagnostics with targeted anticancer treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 124-129 |
Number of pages | 6 |
Journal | Journal of Clinical Ligand Assay |
Volume | 29 |
Issue number | 3 |
State | Published - Sep 2006 |
Keywords
- Cancer
- Drug delivery
- Nanodevice
- Nanoparticle
- Nanotechnology
- Tumor imaging
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical